Antidepressants as a Cause of Autism in Children

Autism spectrum disorder (ASD) represents one of the most formidable diagnostic and therapeutic challenges in contemporary pediatrics, with its prevalence among children steadily increasing.

Despite extensive research efforts, the etiology of this condition remains multifactorial and not yet fully elucidated. Clinicians emphasize the significance of both genetic predispositions and environmental exposures. Researchers identify a potentially critical role for selective serotonin reuptake inhibitors (SSRIs) consumed by pregnant women during the second and third trimesters as a factor that may contribute to the development of autism or other neurodevelopmental disorders in the fetus.

During prenatal development, serotonin (5-hydroxytryptamine) acts not only as a classical neurotransmitter within the central nervous system but also assumes critical morphogenetic functions.

It regulates processes such as cellular proliferation, migration, differentiation, and the formation of synaptic connections during early stages of brain ontogeny. The administration of SSRIs during pregnancy elevates extracellular serotonin concentrations in both maternal and fetal compartments, given that these pharmacological agents readily cross the placental barrier.

A sustained disruption of physiological serotonin homeostasis during critical developmental windows can induce permanent alterations in neural circuitry, thereby significantly heightening the risk of cognitive and behavioral deficits later in the child's life.

The clinical decision to prescribe antidepressants during pregnancy invariably requires a rigorous risk-benefit analysis, weighing potential adverse effects on the offspring against the inherent dangers of untreated maternal depression.

Untreated psychiatric disorders in expectant mothers pose substantial threats to fetal well-being, including prematurity, low birth weight, and compromised prenatal care. Consequently, clinicians must carefully evaluate alternative therapeutic modalities, such as psychotherapy or structured lifestyle interventions, whenever clinically appropriate.

Comprehensive prenatal care that integrates nutritional optimization, meticulous medical monitoring, and judicious pharmacotherapy remains paramount in securing optimal health outcomes for both mother and child.